{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:53:24Z","timestamp":1761630804872},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Hepatorenal syndrome (HRS) does not represent the predominant phenotype of acute kidney injury (AKI) in cirrhosis. Early recognition of HRS helps initiate appropriate therapy. The aims of this review are to present redefinition of AKI, to list new biomarkers, to report recent data on vasopressors in HRS and to propose criteria for simultaneous liver and kidney transplantation (SLKT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Urine output, which was not part of the definition of AKI might be reconsidered as it has an independent prognostic value. Biomarkers (NGAL and IL-18) could help identify ATN. However, cut-off values have to be clarified. Vasopressors with albumin represent first option in HRS. Continuous infusion of terlipressin has a better safety profile than intravenous boluses. SLKT should be considered whenever native kidney recovery is unlikely [i.e. prolonged renal replacement therapy (RRT) and\/or GFR less than 25\u200aml\/min for 6 weeks prior to transplantation].<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>New definitions and recent biomarkers may help differentiate HRS from ATN at an earlier stage. Urine output should be reconsidered in the definitions. Even in patients who are not candidates for transplantation, a short trial of RRT is justified whenever needed. SLKT should be considered whenever posttransplant renal recovery is unlikely.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mcc.0000000000000457","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T17:28:57Z","timestamp":1507742937000},"page":"457-462","source":"Crossref","is-referenced-by-count":7,"title":["Renal dysfunction and cirrhosis"],"prefix":"10.1097","volume":"23","author":[{"given":"Fran\u00e7ois","family":"Durand","sequence":"first","affiliation":[{"name":"Hepatology & Liver Intensive Care, Hospital Beaujon, Clichy, University Paris Diderot, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jody C.","family":"Olson","sequence":"additional","affiliation":[{"name":"Divisions of Critical Care Medicine and Hepatology, University of Kansas Medical Center, Kansas City, Kansas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitra K.","family":"Nadim","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, Keck School of Medicine, University of Southern California, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230913","doi-asserted-by":"crossref","first-page":"e0160394","DOI":"10.1371\/journal.pone.0160394","article-title":"Relevance of new definitions to incidence and prognosis of acute kidney injury in hospitalized patients with cirrhosis: a retrospective population-based cohort study","volume":"11","author":"Tandon","year":"2016","journal-title":"PLoS One"},{"key":"R2-20230913","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29303","article-title":"Significance of oliguria in critically ill patients with chronic liver disease","author":"Amathieu","year":"2017","journal-title":"Hepatology"},{"key":"R3-20230913","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"62","author":"Angeli","year":"2015","journal-title":"J Hepatol"},{"key":"R4-20230913","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","article-title":"Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure","volume":"61","author":"Jalan","year":"2014","journal-title":"J Hepatol"},{"key":"R5-20230913","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1053\/j.ajkd.2015.09.013","article-title":"Pathogenesis of hepatorenal syndrome: implications for therapy","volume":"67","author":"Durand","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"R6-20230913","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1097\/CCM.0b013e318228234b","article-title":"Acute kidney injury in patients with acute lung injury: impact of fluid accumulation on classification of acute kidney injury and associated outcomes","volume":"39","author":"Liu","year":"2011","journal-title":"Crit Care Med"},{"key":"R7-20230913","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"R8-20230913","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/cc11188","article-title":"Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"16","author":"Nadim","year":"2012","journal-title":"Crit Care"},{"key":"R9-20230913","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1681\/ASN.2014070724","article-title":"Classifying AKI by urine output versus serum creatinine level","volume":"26","author":"Kellum","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R10-20230913","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2015.10.019","article-title":"Management of the critically ill patient with cirrhosis: a multidisciplinary perspective","volume":"64","author":"Nadim","year":"2016","journal-title":"J Hepatol"},{"key":"R11-20230913","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/hep.23286","article-title":"Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome","volume":"51","author":"Gluud","year":"2010","journal-title":"Hepatology"},{"key":"R12-20230913","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jhep.2016.05.025","article-title":"Kidney biomarkers in cirrhosis","volume":"65","author":"Francoz","year":"2016","journal-title":"J Hepatol"},{"key":"R13-20230913","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cgh.2016.11.035","article-title":"Urine interleukin 18 and lipocalin 2 are biomarkers of acute tubular necrosis in patients with cirrhosis: a systematic review and meta-analysis","volume":"15","author":"Puthumana","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R14-20230913","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jhep.2016.03.002","article-title":"Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis","volume":"65","author":"Ariza","year":"2016","journal-title":"J Hepatol"},{"key":"R15-20230913","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1111\/ajt.13790","article-title":"Protecting the kidney in liver transplant candidates: practice-based recommendations from the American Society of Transplantation Liver and Intestine Community of Practice","volume":"16","author":"O\u2019Leary","year":"2016","journal-title":"Am J Transplant"},{"key":"R16-20230913","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cgh.2012.11.007","article-title":"Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials","volume":"11","author":"Salerno","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R17-20230913","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"Singh","year":"2012","journal-title":"J Hepatol"},{"key":"R18-20230913","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"key":"R19-20230913","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1","volume":"150","author":"Boyer","year":"2016","journal-title":"Gastroenterology"},{"key":"R20-20230913","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/apt.13912","article-title":"Systematic review with meta-analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1","volume":"45","author":"Gifford","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R21-20230913","first-page":"CD005162","article-title":"Terlipressin for hepatorenal syndrome","volume":"2012","author":"Gluud","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R22-20230913","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatology"},{"key":"R23-20230913","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23283","article-title":"Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome","volume":"51","author":"Nazar","year":"2010","journal-title":"Hepatology"},{"key":"R24-20230913","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1603017","article-title":"Initiation strategies for renal-replacement therapy in the intensive care unit","volume":"375","author":"Gaudry","year":"2016","journal-title":"N Engl J Med"},{"key":"R25-20230913","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13063-016-1249-9","article-title":"Early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury (The ELAIN-Trial): study protocol for a randomized controlled trial","volume":"17","author":"Zarbock","year":"2016","journal-title":"Trials"},{"key":"R26-20230913","doi-asserted-by":"crossref","first-page":"R197","DOI":"10.1186\/cc11682","article-title":"Fluid overload is associated with an increased risk for 90-day mortality in critically ill patients with renal replacement therapy: data from the prospective FINNAKI study","volume":"16","author":"Vaara","year":"2012","journal-title":"Crit Care"},{"key":"R27-20230913","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/lt.22395","article-title":"Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1","volume":"17","author":"Boyer","year":"2011","journal-title":"Liver Transpl"},{"key":"R28-20230913","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/lt.23384","article-title":"Impact of the cause of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome","volume":"18","author":"Nadim","year":"2012","journal-title":"Liver Transpl"},{"key":"R29-20230913","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1097\/TP.0000000000001334","article-title":"Kidney biopsies may help predict renal function after liver transplantation","volume":"100","author":"Pichler","year":"2016","journal-title":"Transplantation"},{"key":"R30-20230913","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/ajt.13631","article-title":"simultaneous liver-kidney allocation policy: a proposal to optimize appropriate utilization of scarce resources","volume":"16","author":"Formica","year":"2016","journal-title":"Am J Transplant"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00075198-201712000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:09:23Z","timestamp":1694632163000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00075198-201712000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000000457","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"value":"1070-5295","type":"print"},{"value":"1531-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}